Cape gooseberry (Physalis peruviana) juice as a modulator agent for hepatocellular carcinoma-linked apoptosis and cell cycle arrest

Biomedicine and Pharmacotherapy

Volumn 94, Issue , 2017, Pages 1129-1137

  Hassan, Hanaa A ^a,c   Serag, Hanaa M ^a   Qadir, Makwan S ^a   Ramadan, Mohamed Fawzy ^b  

^a Mansoura University   (Egypt)

^b Zagazig University   (Egypt)

^c TAIBAH UNIVERSITY   (Saudi Arabia)

Author keywords

Apoptotic markers; Blood indices; Goldenberry; Hepatocellular carcinoma; Malignant hepatoma; Tumor markers

Indexed keywords

C REACTIVE PROTEIN; CASPASE 3; DOXORUBICIN; IMMUNOMODULATING AGENT; PROTEIN BAX; PROTEIN P53; TUMOR NECROSIS FACTOR; PLANT EXTRACT;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; CELL CYCLE ARREST; CELL VIABILITY; COLLAGEN FIBER; CONTROLLED STUDY; DOWN REGULATION; FRUIT JUICE; GOOSEBERRY; HISTOPATHOLOGY; LIVER CELL; LIVER CELL CARCINOMA; LIVER FIBROSIS; LIVER PROTECTION; LIVER TISSUE; MALE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; UPREGULATION; ANIMAL; CELL CYCLE CHECKPOINT; CHEMISTRY; DRUG EFFECT; ENDOTHELIUM CELL; FIBROSIS; FRUIT; FRUIT AND VEGETABLE JUICE; LIVER; LIVER TUMOR; PHYSALIS; RIBES;

ANIMALS; CARCINOMA, HEPATOCELLULAR; CELL CYCLE CHECKPOINTS; DOWN-REGULATION; ENDOTHELIAL CELLS; FIBROSIS; FRUIT; FRUIT AND VEGETABLE JUICES; HEPATOCYTES; LIVER; LIVER NEOPLASMS; MALE; PHYSALIS; PLANT EXTRACTS; RATS; RIBES; UP-REGULATION;

EID: 85027875722     PISSN: 07533322     EISSN: 19506007     Source Type: Journal    
DOI: 10.1016/j.biopha.2017.08.014     Document Type: Article

References (85)

1. Chacko, S., Samanta, S., Hepatocellular carcinoma: a life-threatening disease. Biomed. Pharmacother. 84 (2016), 1679–1688.
2. Jemal, A., Bray, F., Center, M.M., Ferlay, J., Ward, E., Forman, D., Global cancer statistics. CA Cancer J. Clin. 61 (2011), 69–90.
3. Li, P., Yu, Z., He, L., Zhou, D., Xie, S., Hou, H., Geng, X., Knockdown of FOXK1 inhibited the proliferation: migration and invasion in hepatocellular carcinoma cells. Biomed. Pharmacother. 92 (2017), 270–276.
4. Sherif, A.A., Abdelhalim, S.Z., Salim, A.I., Immunohistochemical and biochemical alterations following administration of proanthocyanidin extract in rats hepatocellular carcinoma. Biomed. Pharmacother. 93 (2017), 1310–1319.
5. Arzumanyan, A., Reis, H.M.G.P.V., Feitelson, M.A., Pathogenic mechanisms in HBV- and HCV-associated hepatocellular carcinoma. Nat. Rev. Cancer 13 (2013), 123–135.
6. Anwar, W.A., Khaled, H.M., Amra, H.A., El-Nezami, H., Loffredo, C.A., Changing pattern of hepatocellular carcinoma (HCC) and its risk factors in Egypt: possibilities for prevention. Mutat. Res. 659 (2008), 176–184.
7. Seufi, A.M., Ibrahim, S.S., Elmaghraby, T.K., Hafez, E.E., Preventive effect of the flavonoid, quercetin, on hepatic cancer in rats via Oxidant/antioxidant activity: molecular and histological evidences. J. Exp. Clin. Cancer Res., 28, 2009, 80.
8. Wang, X.O., Ongkeko, W.M., Chen, L., Yang, Z.F., Lu, P., Chen, K.K., Lopez, J.P., Poon, R.T., Fan, S.T., Octamer 4 (Oct4) mediates chemotherapeutic drug resistance in liver cancer cells through a potential Oct4-AKT-ATP-binding cassette G2 pathway. Hepatology 52 (2010), 528–539.
9. El-Serag, H.B., Hepatocellular carcinoma. N. Engl. J. Med. 365 (2011), 1118–1127.
10. Minami, M., Matsumoto, S., Horiu chi, H., Cardiovascular side-effects of modern cancer therapy. Circ. J. 74 (2010), 1779–1786.
11. Stewart, C.F., Ratain, M.J., Pharmacology of cancer chemotherapy, 19.6: topoisomerase interactive agents. DeVitta, V. Jr., Hellman, S., Rosenberg, S.A., (eds.) Cancer: Principles and Practice of Oncology on CD-ROM, 6th ed., 2001, Lippincott Williams and Wilkins, Philadelphia, 1–16.
12. Xian, M., Cao, H., Cao, J., Shao, X., Zhu, D., Zhang, N., Huang, P., Li, W., Yang, B., Ying, M., He, Q., Bortezomib sensitizes human osteosarcoma cells to adriamycin-induced apoptosis through ROS-dependent activation of p-eIF2a/ATF4/CHOP axis. Int. J. Cancer 141 (2017), 1029–1041.
13. Carr, B.I., Nagalla, S., In Hepatocellular Carcinoma: Diagnosis and Treatment. Carr, Brain, (eds.), 2010, Humana Press, New York, USA, 527–568.
14. Kang, H.-G., Wang, B.-Z., Zhang, J., Liu, M.-R., Li, Y.-X., Combination of temsirolimus and adriamycin exhibits an enhanced antitumor effect in hepatocellular carcinoma. Clin. Res. Hepatol. Gastroenterol. 41 (2017), 197–203.
15. Kaefer, C.M., Milner, J.A., The role of herbs and spices in cancer prevention. J. Nutr. Biochem. 19 (2008), 347–361.
16. Ramakrishnan, G., Raghavendran, H.R., Vinodhkumar, R., Devaki, T., Suppression of N-nitrosodiethylamine induced hepatocarcinogenesis by silymarin in rats. Chem. Biol. Interact. 161 (2006), 104–114.
17. Hassan, H.A., Abdel-Aziz, A.F., Evaluation of free radical- scavenging and anti-oxidant properties of black berry against fluoride toxicity in rats. Food Chem. Toxicol. 48 (2010), 1999–2004.
18. Hassan, H.A., Isa, A.M., El-Kholy, W.M., Nour, S.E., Testicular disorders induced by plant growth regulators: cellular protection with proanthocyanidins grape seeds extract. Cytotechnology 65 (2013), 851–862.
19. Hassan, H.A., Edress, G.M., El-Gamal, E., El-Sayed, E.A., Amelioration of cisplatin-induced nephrotoxicity by grape seed proanthocynidin extract and fish oil is mediated by lowering oxidative stress and DNA damage. Cytotechnology 66 (2014), 419–429.
20. Ramadan, M.F., Moersel, J.-T., Impact of enzymatic treatment on chemical composition, physicochemical properties and radical scavenging activity of goldenberry (Physalis peruvianaL.) juice. J. Sci. Food Agric. 87 (2007), 452–460.
21. Ramadan, M.F., Bioactive phytochemicals, nutritional value, and functional properties of cape gooseberry (Physalis peruviana): an overview. Food Res. Int. 44 (2011), 1830–1836.
22. Ramadan, M.F., Physalis peruviana pomace suppresses high-cholesterol diet-induced hypercholesterolemia in rats. Grasas Aceites 63 (2012), 411–422.
23. Szefer, P., Nriagu, J., Mineral Components in Foods. 2007, CRC, New York, 480.
24. Wang, I.K., Lin-Shiau, S.Y., Lin, J.K., Induction of apoptosis by apigenin and related flavonoids through cytochrome c release and activation of caspase-9 and caspase-3 in leukaremia HL-60 cells. Eur. J. Cancer 35 (1999), 1517–1525.
25. Serag, H.M., Hassan, H.A., Qadir, M.S., Efficiency of cape gooseberry in attenuating some biochemical disorders and oxidative stress associated with hepatocellular carcinoma. Wulfenia 22:11 (2015), 62–89.
26. Shariff, N., Sudarshana, M.S., Umesha, S., Hariprasad, P., Antimicrobial activity of rauvolfiatetraphylla and Physalis minima leaf and callus extracts. Afr. J. Biotech. 5 (2006), 946–950.
27. Helvaci, S., Kökdil, G., Kawai, M., Duran, N., Duran, G., Güvenc, A., Antimicrobial activity of the extracts and physalin D from Physalis alkekengi and evaluation of antioxidant potential of physalin. D. Pharm. Biol. 48 (2010), 142–150.
28. Sarkar, V.A., Basak, R., Bishayee, A., Basak, J., Chatterjee, M., B-carotene inhibits rat liver chromosomal aberrations and DNA chain break after a single injection of diethylnitrosamine. Br. J. Cancer 76 (1997), 855–861.
29. Subramanian, P., Mirunalini, S., Dakshayani, K.B., Pandi-Perumal, S.R., Trakht, I., Cardinali, D.P., Prevention by melatonin of hepatocarcinogenesis in rats injected with N-nitrosodiethylamine. J. Pineal Res. 43 (2007), 305–312.
30. Singha, B.N., Braj, R., Singh, B.R., Sarma, B.K., Singha, H.B., Potential chemoprevention of N-nitrosodiethylamine-induced hepatocarcinogenesis by polyphenolics from acacia niloticabark. Chem. Biol. Interact. 181 (2009), 20–28.
31. Sakr, S.A., Mahran, H.A., Lamfon, H.A., Protective effect of ginger (Zingibero fficinale) on adriamycin-induced hepatotoxicity in albino rats. J. Medic. Plants Res. 5 (2011), 133–140.
32. Arun, M., Asha, V.V., Preliminary studies on anti-hepatotoxic effect of Physalis peruviana. (Solanaceae) against carbon tetrachloride induced acute liver injury in rats. J. Ethnopharmacol. 111 (2007), 110–114.
33. Dacie, J.V., Lewis, S.M., Practical Haematology. 7th ed., 1991, Churchill Livingstone, Edinburgh, 521–534.
34. Aggarawal, B.B., Human tumor necrosis factor production, purification and characterization. J. Biol. Chem. 260 (1985), 2345–2354.
35. Peltola, H., Saarinen, U.M., Siimes, M.A., C-reactive protein in rapid diagnosis and follow-up of bacterial septicemia in children with leukemia. Pediatr. Infect. Dis. 2 (1983), 370–373.
36. Marsch, W., colorimetric method for determination of arginase. Chin. Chem., 11, 1965, 624.
37. Nicoletti, I., Mannucci, R., Migloirati, G., Riccardi, C., Grignani, F., Common method for measuring apoptotic cell death by flow cytometry. Purdue Cytometry CD-ROM Series 3 (2001), 1–9.
38. Brothereck, I., Shenton, B.K., Cowan, W.K., Angus, B., Horne, C.H.W., Higgs, M.J., Lennard, T.W.J., P53 expression measured by flow cytometry. A comparison of three monoclonal antibodies and the relationship with grade and DNA ploidy in breast cancer. Cancer Imuno. Imunother. 41 (1995), 146–150.
39. Drury, R.A., Wallington, E.A., Cancerson, R., Carlton's Histopathological Techniques. 4th ed., 1976, Oxford university press, Oxford.
40. Sheehan, D., Hrapchak, B., Theory and Practice of Histotechnology. 2nd ed., 1980, Battelle Press, Ohio, 189–190.
41. Waller, R.A., Duncan, D.B., Bayes rule for the symmetric multiple comparison problems. Am. J. Stat. Assoc. 64 (1969), 1484–1503.
42. Venook, A.P., Papandreou, C., Furuse, J., Guevara, L.L.D., The incidence and epidemiology of hepatocellular carcinoma: a global and regional perspective. Oncologist 15:Suppl. 4 (2010), 5–13.
43. Kurt, R., Meric, H., Aslan, k., Cil, M., Laminated veneer lumber (LVL) manufacturing using three hybrid poplar clones. Turkish. J. Agric. For. 36 (2012), 237–245.
44. Kurt, M., Akdogan, M., Onal, I.K., Kekilli, M., Arhan, M., Shorbagi, A., Aksu, S., Kurt, O.K., Haznedaroglu, I.C., Endoscopic topical application of ankaferd blood stopper for neoplastic gastrointestinal bleeding: a retrospective analysis. Dig. Liver Dis. 42 (2010), 196–199.
45. Bemelmans, M.H., van Tits, L.J., Buurman, W.A., Tumor necrosis factor: function, release and clearance. Crit. Rev. Immunol. 6 (1996), 1–11.
46. Bird, G.L.A., Sheron, N., Goka, J., Alexandra, G., Williams, R.S., Increased plasma tumor necrosis factor in severe alcoholic hepatitis. Ann. Intern. Med. 112 (1990), 917–920.
47. Schook, L.B., Lockwood, J.F., Yang, S.D., Myers, M.J., Dimethylnitrosamine (DMN)-induced IL-1 b, TNF-a and IL-6 inflammatory cytokine expression. Toxicol. Appl. Pharmacol. 116 (1992), 110–116.
48. Chrzanowska, A., Krawczyk, M., Baranczyk-Kuzma, A., Changes in arginase isoenzymes pattern in human hepatocellular carcinoma. Biochem. Biophys. Res. Commun. 377 (2008), 337–340.
49. Van de Poll, M.C., Siroen, M.P., Van Leeuwen, P.A., Interorgan amino acid exchange in humans: consequences for arginine and citrulline metabolism. Am. J. Clin. Nutr. 85 (2007), 167–172.
50. Garcia, E.J., Lawson, D., Cotsonis, G., Hepatocellular carcinoma and markers of apoptosis (bcl-2, bax, bcl-x): prognostic significance. Appl. Immunohistochem. Mol. Morphol. 10 (2002), 210–217.
51. Watanabe, J., Kushihata, F., Honda, K., Prognostic significance of Bcl-xL in human hepatocellular carcinoma. Surgery 135 (2004), 604–612.
52. Miyashita, T., Krajewski, S., Krajewska, M., Wang, H.G., Lin, H.K., Liebermann, D.A., Hoffman, B., Reed, J.C., Tumor suppressor p53 is a regulator of bcl-2 and bax gene expression in vitro and in vivo. Oncogene 9 (1994), 1799–1805.
53. Haldar, S., Negrini, M., Monne, M., Sabbioni, S., Croce, C.M., Down-regulation of bcl-2 by p53 in breast cancer cells. Cancer Res. 54 (1994), 2095–2097.
54. Osada, S., Saji, S., Kuno, T., Clinical significance of combination study of apoptotic factors and proliferating cell nuclear antigen in estimating the prognosis of hepatocellular carcinoma. J. Surg. Oncol. 85 (2004), 48–54.
55. Farazi, P.A., Glickman, J., Horner, J., Depinho, R.A., Cooperative interactions of p53 mutation, telomere dysfunction, and chronic liver damage in hepatocellular carcinoma progression. Cancer Res. 66 (2006), 4766–4773.
56. Hirohashi, S., Pathology and molecular mechanisms of multistage human hepatocarcinogenesis. Princess Takamatsu Symp. 22 (1991), 87–93.
57. Kondo, M., Marusawa, H., Ueda, Y., Katsurada, A., Kawasome, C., Takami, S., Kinoshita, M., Ikai, I., Yamaoka, Y., Chiba, T., Diverse p53 gene aberration in hepatocellular carcinoma detected by dual-color fluorescence in situ hybridization. J. Gastroenterol. Hepatol. 19 (2004), 1066–1073.
58. Kaufmann, S.H., Cell death induced by topoisomerase-targeted drugs: more questions than answers. Biochim. Biophys. Acta 1400 (1998), 195–211.
59. Persad, R., Liu, C., Wu, T.T., Houlihan, P.S., Hamilton, S.R., Diehl, A.M., Rashid, A., Overexpression of caspase-3 in hepatocellular carcinomas. Mod. Pathol. 17 (2004), 861–867.
60. Van Genderen, H.O., Kenis, H., Hofstra, L., Narula, J., Reutelingsperger, C.P., Extracellular annexin A5: functions of phosphatidylserine-binding and two-dimensional crystallization. Biochim. Biophys. Acta 1783 (2008), 953–963.
61. Vermes, I., Haanen, C., Steffens-Nakken, H., Reutelingsperger, C., A novel assay for apoptosis-flow cytometric detection of phosphatidylserine expression on early apoptotic cells using fluorescein labelled Annexin V. J. Immuno. Methods 184:1 (1995), 39–51.
62. Prossnitz, E.R., Ye, R.D., The N-formyl peptide receptor: a model for the study of chemoattractant receptor structure and function. Pharmacol. Ther. 74:1 (1997), 73–102.
63. Arur, S., Uche, U.E., Rezaul, K., Fong, M., Scranton, V., Cowan, A.E., Mohler, W., Han, D.K., Annexin I is an endogenous ligand that mediates apoptotic cell engulfment. Dev. Cell 4:4 (2003), 587–598.
64. Oh, P., Li, Y., Yu, J., Durr, E., Krasinska, K.M., Carver, L.A., Testa, J.E., Schnitzer, J.E., Subtractive proteomic mapping of the endothelial surface in lung and solid tumours for tissue-specific therapy. Nature 429:6992 (2004), 629–635.
65. Kleiner, D.E., Brunt, E.M., Van Natta, M., Behling, C., Contos, M.J., Cummings, O.W., Ferrell, L.D., Liu, Y.C., Torbenson, M.S., Unalp-Arida, A., Yeh, M., McCullough, A.J., Sanyal, A.J., Design and validation of a histological scoring system for nonalcoholic fatty liver disease. Hepatology 41 (2005), 1313–1321.
66. Ganie, S.A., Zargar, B.A., Masood, A., Zargar, M.A., Hepatoprotective and antioxidant activity of rhizome of Podophyllum hexandrum against carbon tetra chloride induced hepatotoxicity in rats. Biomed. Environ. Sci. 26:3 (2013), 209–221.
67. 4 included hepatoxicity in rats. 4 Biosci. Biotechnol. Biochem. 77 (2013), 909–916.
68. Geng, Y., Yu, Q., Sicinska, E., Das, M., Schneider, J.E., Bhattacharya, S., Rideout, W.M., Bronson, R.T., Gardner, H., Sicinski, P., Cyclin E ablation in the mouse. Cell 114 (2003), 431–443.
69. Pang, B., Qiao, X., Janssen, L., Velds, A., Groothuis, T., Kerkhoven, R., Nieuwland, M., Ovaa, H., Rottenberg, S., Van Tellingen, O., Janssen, J., Huijgens, P., Zwart, W., Neefjes, J., Drug-induced histone eviction from open chromatin contributes to the chemotherapeutic effects of doxorubicin. Nat. Commun., 4, 2013, 908, 10.1038/ncomms.2921 (PMID. 23715267).
70. Sawamura, A.O., Aoyama, T., Tamakoshi, K., Mizuno, K., Suganuma, N., Kikkawa, F., Tomoda, Y., Transfection of humancytochrome P-450 reductasec DNA and its effect on the sensitivity to toxins. Oncology 53 (1996), 406–411.
71. Hassan, H.A., Al-Rawi, M.M., Evaluation grape seeds proanthocyanidin extract as a hepatic-reno-protective agent against gibberellic acid induced oxidative stress and cellular alterations. Cytotechnology 65 (2013), 567–576.
72. Ombwara, F., Wamosho, L., Mugai, E., The effect of nutrient solution strength and mycorrhizal inoculation on anthesis in Physalis peruviana. Proceedings of the Fourth Workshop on Sustainable Horticultural Production in the Tropics, Kenya: Department of Horticulture. Jomo Kenyatta University of Agriculture and Technology, 2005, 117–123.
73. Fang, S.T., Liu, J.K., Li, B., Ten new withanolides from Physalis peruviana. Steroids 77:1–2 (2012), 36–44.
74. Zhang, Y.J., Deng, G.F., Xu, X.R., Wu, S., Li, S., Li, H.B., Chemical components and bioactivities of Cape Gooseberry (Physalis peruviana). Int. J. Food Nutr. Safety 3 (2013), 15–24.
75. Zhao, Y., Berry fruit, value-added products for health promotion. Zhoa, Y., (eds.), 2007, CRC press, NW (USA) (ISBN-10: 0-8493-5802-5807).
76. Lee, S.W., Pan, M.H., Chen, C.M., Chen, Z.T., Withangulatin I, a new cytotoxic withanolide from Physalis angulata. Chem. Pharm. Bull. (Tokyo) 56 (2008), 234–236.
77. Chang, J.C., Lin, C.C., Wu, S.J., Lin, D.L., Wang, S.S., Miaw, C.L., Ng, L.T., Antioxidative and hepatoprotective effects of Physalis peruviana extract against acetaminophen induced liver injury in rats. Pharm. Bio. 46 (2008), 724–731.
78. Wu, S.J., Ng, L.T., Huang, Y.M., Lin, D.L., Wang, S.S., Huang, S.N., Lin, C.C., Antioxidant activities of Physalis peruviana. Biol. Pharm. Bull. 28 (2005), 963–966.
79. Qiu, L., Jiang, Z.H., Liu, H.X., Chen, L.X., Qu, G.X., Qiu, F., Flavonoid glycosides of the calyx Physalis. J. Shenyang Pharm. Uni. 24 (2007), 744–747.
80. Janbaz, K.H., Saeed, S.A., Gilani, A.H., Studies on the protective effects of caffeic acid and quercetin on chemical induced hepatotoxicity in rodents. Phytomedicine 11 (2004), 424–430.
81. Hollman, P.C.H., Van Trijp, J.M.P., Mengelers, M.J.B., De Vries, J.H.M., Katan, M.B., Bioavailability of the dietary antioxidant flavonol quercetin in man. Cancer Lett. 114 (1997), 139–140.
82. Tatsimo, S.J.N., Tamokou, J.D.D.D., Havyarimana, L., Antimicrobial and antioxidant activity of kaempferol rhamn side derivatives from Bryophyllum pinnatum. BMC Res. Notes, 5, 2012, 158.
83. Kahraman, A., Bronk, S.F., Cazanave, S., Matrix met alloproteinase inhibitor, CTS-1027, attenuates liver injury and fibrosis in the bile duct-ligated mouse. Hepatol. Res. 39 (2009), 805–813.
84. Tatiya, A.U., Surana, S.J., Sutar, M.P., Gamit, N.H., Hepatoprotective effect of poly herbal formulation against various hepatotoxic agents in rats. Pharmacognosy Res. 4 (2012), 50–56.
85. Vassiliadis, E., Larsen, D.V., Clausen, R.E., Measurement of co3-610, a potential liver biomarker derived from matrix etalloproteinase-9 degradation of collagen type iii, in a rat model of reversible carbon-tetrachloride-induced fibrosis. Biomarker Insights 6 (2011), 49–58.